Why Bristol-Myers (BMY) is Poised to Beat Earnings Estimates AgainZacks Investment Research • 10/01/19
This Bristol-Partnered Biotech Stock Just Fumbled On A Cancer StudyInvestors Business Daily • 09/26/19
Bristol-Myers cancer drug Opdivo fails to meet a primary endpoint in phase 3 trialMarket Watch • 09/05/19